For Research Purposes Only

Research Summary

Growth Hormone Secretagogue Research Overview

Growth hormone secretagogues (GHS) stimulate the pituitary gland to release GH naturally, offering an alternative to exogenous GH injection. Two main classes exist: GHRH analogs (CJC-1295, Tesamorelin) and ghrelin mimetics (Ipamorelin, GHRP-2, GHRP-6, Hexarelin).

Key Points

Two classes: GHRH analogs and ghrelin mimetics
Combination produces synergistic GH release
Ipamorelin is most selective with fewest side effects
Tesamorelin is the only FDA-approved GH secretagogue
GH declines ~14% per decade after age 30

Step-by-Step Guide

1

Understand GH Physiology

GH is released in pulses regulated by GHRH (stimulatory) and somatostatin (inhibitory). IGF-1 mediates many GH effects. GH declines ~14% per decade after age 30, driving interest in secretagogues.

2

Compare GHRH Analogs

CJC-1295 (no DAC, with DAC) and Tesamorelin stimulate the GHRH receptor. They amplify the natural GH pulse signal. Tesamorelin is FDA-approved (HIV lipodystrophy). CJC-1295 is research-only.

3

Compare Ghrelin Mimetics

Ipamorelin: most selective, minimal side effects. GHRP-2: strong GH release but increases cortisol and prolactin. GHRP-6: strong GH release with significant hunger increase. Hexarelin: strongest but most desensitization.

4

Review Combination Research

GHRH + GHRP combinations produce synergistic GH release (2-3x either alone). The Ipamorelin + CJC-1295 no DAC combination is the most popular due to selectivity and synergy.

5

Assess Evidence Levels

Tesamorelin: Phase 3 clinical trials, FDA-approved. Ipamorelin: Phase 2 clinical trials completed. CJC-1295: limited clinical data. GHRP-2/6: decades of research but no FDA approval. Hexarelin: clinical trials in cardiac patients.

Warnings & Precautions

  • !GH elevation carries risks: insulin resistance, joint issues, potential cancer growth.
  • !Only Tesamorelin has FDA approval among GH secretagogues.
  • !Pituitary desensitization can occur with continuous use.
  • !IGF-1 levels should be monitored during any GH-elevating protocol.

Frequently Asked Questions

Are GH secretagogues safer than HGH injections?

Theoretically, secretagogues maintain pulsatile GH release and are subject to natural feedback mechanisms, while exogenous HGH bypasses these controls. However, this theoretical advantage lacks comparative clinical evidence. Secretagogues also carry unique risks.

Which GH secretagogue is best?

Depends on the goal. For selectivity/safety: Ipamorelin. For FDA-approved clinical use: Tesamorelin. For maximum GH release: GHRP-2 or Hexarelin (with more side effects). The Ipamorelin + CJC-1295 stack is the most popular all-around choice.

Do GH secretagogues work in older adults?

Yes, but with diminished response. The pituitary retains capacity to release GH in response to stimulation throughout life, but the magnitude decreases with age. Older adults may need higher doses for equivalent GH elevation compared to younger subjects.

Related Protocols

Disclaimer: Protocol information is for educational purposes only. Not medical advice. Consult healthcare professionals.